Lawmaker has introduced VALID Compounding Act to strengthen federal regulations for compounding pharmacies
WASHINGTON, D.C. - With both Congressional and Massachusetts state hearings scheduled this week on the fungal meningitis outbreak caused by contaminated drugs from a compounding pharmacy located in his district, Congressman Edward J. Markey (D-Mass.) will hold a press conference where he will be joined by a Baltimore, Maryland-based patient who suffered severe adverse reactions after receiving two steroid injections from drugs manufactured at the New England Compounding Center (NECC). Rep. Markey will also be joined by a patient advocate in calling for strengthening regulations for compounding pharmacies. To date, 32 people have died and 438 more sickened in 19 states by injectable steroids from NECC. Rep. Markey introduced H.R. 6584, the Verifying Authority and Legality in Drug (VALID) Compounding Act to give the Food and Drug Administration new authority to oversee compounding pharmacy practices throughout the country.
WHAT: Press conference calling for action to strengthen oversight of compounding pharmacies with victim of contaminated drugs and patient advocate
- Rep. Edward J. Markey (D-Mass.), a senior member of the House Energy and Commerce Committee
- Gerald and Harriet Cohen
- Diana Zuckerman, Ph.D., President, National Research Center for Women & Families, Cancer Prevention and Treatment Fund
WHEN: 9 AM, Wednesday, November 14, 2012
WHERE: 2218 Rayburn House Office Building, Washington, D.C.